Literature DB >> 19011875

[Current value of stem-cell transplantation in autoimmune diseases].

I Kötter1, M Schmalzing, J Henes, W Vogel, L Kanz.   

Abstract

Transplantations of autologous or allogeneic stem cells from bone marrow or peripheral blood are preformed for the treatment of resistant autoimmune diseases. Data have been systematically collected since 1996. We describe the historical development of this procedure for autoimmune diseases, the possible mechanisms of action, the options for stem cell collection, purging and conditioning (high-dose chemotherapy, combination with monoclonal anti-T- or B-cell antibodies, total body irradiation), as well as the reported outcomes in the literature.

Entities:  

Mesh:

Year:  2008        PMID: 19011875     DOI: 10.1007/s00393-008-0386-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  33 in total

1.  Rationale for high-dose cyclophosphamide and medium-dose total body irradiation in the conditioning of children with progressive systemic and polyarticular juvenile chronic arthritis before autologous stem cell transplantation.

Authors:  J M Vossen; D M Brinkman; B Bakker; P M Hoogerbrugge; R ten Cate
Journal:  Rheumatology (Oxford)       Date:  1999-08       Impact factor: 7.580

2.  Risk taking in patients with rheumatoid arthritis: are the risks of haemopoietic stem cell transplantation acceptable?

Authors:  J M van Laar; R J Verburg; J K Sont
Journal:  Rheumatology (Oxford)       Date:  2000-06       Impact factor: 7.580

3.  Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: guidance for BSPAR members--executive summary.

Authors:  H Foster; J Davidson; E Baildam; M Abinun; L R Wedderburn
Journal:  Rheumatology (Oxford)       Date:  2006-10-31       Impact factor: 7.580

Review 4.  Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?

Authors:  Richard K Burt; Alessandro Testori; Alessandro Testor; Robert Craig; Bruce Cohen; Robert Suffit; Walter Barr
Journal:  J Autoimmun       Date:  2008-02-01       Impact factor: 7.094

5.  Autologous hematopoietic stem cell transplantation for autoimmune diseases.

Authors:  A Gratwohl; J Passweg; C Bocelli-Tyndall; A Fassas; J M van Laar; D Farge; M Andolina; R Arnold; E Carreras; J Finke; I Kötter; T Kozak; I Lisukov; B Löwenberg; A Marmont; J Moore; R Saccardi; J A Snowden; F van den Hoogen; N M Wulffraat; X W Zhao; A Tyndall
Journal:  Bone Marrow Transplant       Date:  2005-05       Impact factor: 5.483

6.  Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases.

Authors:  W Hinterberger; M Hinterberger-Fischer; A Marmont
Journal:  Bone Marrow Transplant       Date:  2002-12       Impact factor: 5.483

7.  Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.

Authors:  B Maurer; M Hensel; R Max; C Fiehn; A D Ho; H M Lorenz
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

Review 8.  Hematopoietic stem cell transplantation for severe rheumatoid arthritis.

Authors:  J J Moore; J Snowden; S Pavletic; W Barr; R Burt
Journal:  Bone Marrow Transplant       Date:  2003-08       Impact factor: 5.483

9.  Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

Authors:  R A Brodsky; L L Sensenbrenner; R J Jones
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

10.  Autologous stem cell transplantation improves microcirculation in systemic sclerosis.

Authors:  I Miniati; S Guiducci; M L Conforti; V Rogai; G Fiori; M Cinelli; R Saccardi; S Guidi; A Bosi; A Tyndall; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2008-02-28       Impact factor: 19.103

View more
  2 in total

Review 1.  Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives.

Authors:  Andre F Steinert; Lars Rackwitz; Fabian Gilbert; Ulrich Nöth; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2012-02-22       Impact factor: 6.940

2.  Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Authors:  J A Snowden; R Saccardi; M Allez; S Ardizzone; R Arnold; R Cervera; C Denton; C Hawkey; M Labopin; G Mancardi; R Martin; J J Moore; J Passweg; C Peters; M Rabusin; M Rovira; J M van Laar; D Farge
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.